Ann: PTX-100 Ph1b results show excellent safety & efficacy in TCL, page-32

I was personally disappointed by today's data.

The data we had before had 2 CR's and many ongoing.

Today's just shows a few more ongoing, some PD and most of those new enrolled pulling out.

Thinking about from the sp highs a few years ago - Omnicar isn't really moving atm (fair enough, not enough cash), the TF venture didn't turn into a deal (like I hoped) and the new ptx100 data hasn't inspired me.

Hopes are now on a Cellpryme deal(s).

But if I look at imu from their recent sp highs, they have developed and progressed so much in that time.

cheers